Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06779513

Acronym

VANESSA

Enrollment

Registered

2025-01-16

Start date

2024-01-01

Completion date

2025-03-15

Last updated

2025-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension. Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.

Interventions

DIAGNOSTIC_TESTEchocardiohraphy

Transthoracal echocardiography for diastolic function assessment

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Essential hypertension

Exclusion criteria

* Secondary or resistant hypertension * LVEF\<55% * Congenital heart disease * Infiltrative cardiomyopathy * Coronary artery disease * Chronic kidney disease * Valvular heart disease * Bundle branch block * Arrhythmia

Design outcomes

Primary

Measure	Time frame	Description
Diastolic Dysfunction	Up to 1 weeks	Diastolic Dysfunction found in transthoracal echocardiography assessment

Countries

Indonesia

Contacts

Primary ContactLeo Deddy Pradipta

dancingdeagle@gmail.com+6281316499074

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026